Recruiting NA INTERVENTIONAL 1-arm
NCT06810986
Cohort Study Evaluating Glycaemic Control in Individuals with Type 2 Diabetes Mellitus Through Digital Therapeutics (DM DTx) (DM DTx)
Phase 2 Research Study for Type 2 Diabetes Mellitus Through Digital Therapeutics
Sponsor: EVYD Technology
Conditions
Type 2 Diabetes Mellitus (T2DM)
Interventions
16-week digital intervention
Updated 2 times since 2025 Last updated: Jan 31, 2025 Started: Aug 20, 2024 Primary completion: Jul 31, 2025 Completion: Jul 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06810986, this NA trial focuses on Type 2 Diabetes Mellitus (T2DM) and remains actively recruiting participants. Sponsored by EVYD Technology, it has been updated 2 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
2 versions recorded-
Sep 2025 — Present [monthly]
Recruiting NA
-
Mar 2025 — Sep 2025 [monthly]
Recruiting NA
First recorded
Aug 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- EVYD Technology
- Ministry of Health, Brunei Darussalam
Data source: EVYD Technology
For direct contact, visit the study record on ClinicalTrials.gov .